Preventive Effects of Omega-3 and Omega-6 Fatty Acids on Peroxide Mediated Oxidative Stress Responses in Primary Human Trabecular Meshwork Cells by Tourtas, Theofilos et al.
Preventive Effects of Omega-3 and Omega-6 Fatty Acids
on Peroxide Mediated Oxidative Stress Responses in
Primary Human Trabecular Meshwork Cells
Theofilos Tourtas
., Marco T. Birke
., Friedrich E. Kruse, Ulrich-Christoph Welge-Lu ¨ssen, Kerstin Birke*
Department of Ophthalmology, University Hospital Erlangen, Erlangen, Germany
Abstract
Pathologic processes in glaucoma include increased apoptosis, accumulation of extracellular material in the trabecular
meshwork and optic nerve, condensations of the cytoskeleton and precocious cellular senescence. Oxidative stress was
shown to generate these alterations in primary ocular cells. Fatty acids omega-3 and -6 are alleged to constitute a
prophylaxis against these deleterious effects. Here, we tested actual preventive effects omega-3 and -6 against peroxide
induced stress responses in primary human trabecular meshwork cells. Changes of mitochondrial activity, proliferation, heat
shock proteins, extracellular matrix components, and inflammatory markers were evaluated. Alterations of the cytoskeleton
were evaluated by phalloidin labeling. Here we report a repressive effect of omega-6 on metabolic activity and proliferation,
which was not detected for omega-3. Both agents were able to prevent the anti-proliferative effect of H2O2, but only
omega-3 prevented metabolic repression. Expression of heat shock protein 27 was unaltered by both fatty acids, whereas
heat shock protein 90 was significantly induced by both. Omega-6 increased fibronectin and connective tissue growth
factor synthesis, as well as the amount of secreted fibronectin. Omega-3, instead, induced plasminogen activator inhibitor 1
synthesis. H2O2 further increased fibronectin production in omega-6 supplemented cells, which was not the case in omega-
3 treated cells. H2O2 stimulation of plasminogen activator inhibitor 1 and connective tissue growth factor was repressed by
both fatty acids. Both fatty acids appeared to abolish H2O2 mediated stimulation of nuclear factor kB and IL-6, but not IL-1a
and IL-8. H2O2 induced formation of cross-linked actin networks and stress fibers, which was reduced by preemptive
application of omega-3. Omega-6, in contrast, had no protective effect on that, and even seemed to promote condensation.
Based on the observed side effects of omega-6, omega-3 appears to be the more beneficial fatty acid in respect of
prophylactic intake for prevention of a glaucomatous disease.
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Introduction
The trabecular meshwork (TM) accounts for about 70–90% of
total aqueous humor (AH) outflow from the anterior chamber in
the adult human eye. Moreover, the TM constitutes an outflow
resistance and thereby determines the intraocular pressure (IOP).
Increase of outflow resistance and IOP, eventually, is a major risk
factor in primary open angle glaucoma (POAG) [1]. POAG
patients exhibit specific morphological peculiarities as accumula-
tions of extracellular matrix material (ECM) and condensation or
clustering of the cytoskeleton. Frequently, signs of subclinical
inflammation are reported. Moreover, deregulations on the
cellular level affecting signaling pathways regulating apoptosis,
cellular senescence and cell cycle control were observed in ocular
cells of POAG patients [1,2,3,4].
In vitro, such glaucoma-characteristic alterations were detected
due to artificially induced oxidative stress in cultured human TM
cells (hTM) [5,6,7,8]. This lead to the hypothesis that oxidative
stress might either be responsible or at least involved in the onset
and progression of the TM changes observed in POAG.
Supporting that, evidence for a higher frequency of impaired
mitochondrial function has been reported in POAG patients
[8,9,10,11]. Tanwar et al. (2010) identified conspicuous variations
in the mitochondrial DNA of patients with primary congenital
glaucoma affecting the respiratory chain and leading to increased
production of reactive oxygen species (ROS) [12]. Izzotti et al.
(2003) found a deletion mutation of the glutathione S-transferase
Mu 1 (GSTM1) gene in POAG patients which correlated with an
increase of 8-hydroxydeoxyguanosine (8-OH-dG), a marker of
DNA damage and precocious senescence, in TM cells [13]. Sacca
et al. (2005) described a distinct correlation between oxidative
DNA damage in the TM, visual field reduction and IOP increase
[14]. Previously, Abu-Amero et al. (2006) had already observed a
significant reduction of the mitochondrial respiratory activity in
patients with POAG [9]. Mitochondrial dysfunctions and a
reduced mitochondrial respiratory activity favor accumulation of
ROS. Studies to evaluate the total reactive anti-oxidative potential
of the aqueous humor state a significantly decreased anti-oxidative
capacity in patients with POAG [15,16,17,18]. All these findings
suggest a constantly heightened oxidative stress level in patients
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pathogenesis of POAG has become focus of experimental studies
[14,18,19,20] and became a potential new target for therapeutic
approaches.
In this context, preemptive application of dietary supplements
with alleged preventive capacities from oxidative stress was
proposed in terms of a prophylaxis or even therapy of ocular
degenerative diseases [21]. Amongst these supplements, essential
fatty acids omega (v)-6 and v-3 are of special interest due to their
reported anti-inflammatory, antithrombotic, hypolipidemic, and
vasodilatory capacities [22,23]. There is already consistent
evidence that v-3 fatty acids are protective agents against
ischemia-, light-, oxygen-, inflammation-, and age-associated
pathologies of the vascular and neural retina [24,25]. But there
are also reports that indicate the requirement of a fine-tuned
balance of fatty acid intake, as a misbalanced v-3/ v-6 ratio or
excessive amounts of v-6 fatty acids are suspected to promote
cardiovascular, inflammatory and autoimmune diseases or cancer
[26,27,28].
In the presented study, the effects of v-6 and v-3 fatty acids and
their preventing capacities against oxidative stress induced
glaucoma-associated expression changes were analyzed in culti-
vated hTM, the most vulnerable ocular tissue to oxidative stress
[7,11,29].
Materials and Methods
Primary hTM cell culture and treatment
Explant cultures of hTM were obtained from the eye bank of
the Ludwig-Maximilians-University, Munich, Germany. Methods
of securing human tissue were humane, included proper consent
and approval, complied with the Declaration of Helsinki and were
approved by the ethic committee of the Department of Medicine
of the Friedrich-Alexander-University Erlangen-Nuremberg. The
consent statement was written (EK_No. 4346-CH). Monolayer
cultures were established from eyes obtained 4 to 8 hours post
mortem of five human donors (40–50 years) without any history of
eye diseases. Cells were propagated in complete F10 (Ham’s F10
medium supplemented with 10% fetal bovine serum [FBS], 10 U/
ml penicillin, 10 mg/ml streptomycin, and 0.25 mg/ml Fungizone
Mix; all from PAN
TM Biotech GmbH, Aidenbach, Germany)
under standard cell culture conditions in 6-well (RNA/ protein
extraction) or 24 well (CCK-8/BrdU/IF-labeling) cell culture
plates (Techno Plastic Products AG, Trasadingen, Switzerland).
To test the effects of v-3 or v-6 fatty acids, confluent hTM of
passages 3 to 5 were pre-incubated in low F10 (Ham’s F10/1%
FBS) for 24 hours. Then the medium was substituted by low F-10
supplemented to nontoxic 50 mM v-3 [30] or 16 mM v-6 [31]
fatty acids (both from Sigma-Aldrich, Taufkirchen, Germany).
After 24 hours, medium was replaced by fresh v-3 or v-6
containing medium for an additional 24 hours incubation. After
48 hours in total, oxidative stress was induced by exposure to
nontoxic 300 mM hydrogen peroxide [6] (H2O2, Sigma-Aldrich)
for 1 hour. Afterwards the cells were washed with PBS and further
cultured with the distinct media for 1 hour. In control cultures, the
medium was changed at the same time points, but no H2O2 was
added.
Cell counting kit-8
Mitochondrial metabolism was quantified at 0, 24 and 48 hours
after indicated treatments with a Cell Counting Kit-8 (CCK-8,
Dojindo Molecular Technologies, Rockville, MD) according to the
manufactures’ instructions. 100 ml aliquots of the medium were
transferred to 96 well plates and absorbance at 450 nm was
measured with a spectrophotometer (MultiscanH Spectrum;
Thermo Electron Corporation, Karlsruhe, Germany). Measure-
ments were done as triplicates of hTM from 5 different donors in 3
independent experiments. Values represent mean averages 6 SD
(n=45).
BrdU incorporation
hTM proliferation was quantified with a Bromodeoxyuridine
(BrdU) detection kit (Cell Proliferation ELISA, BrdU [colorimet-
ric]; Roche Diagnostics, Mannheim, Germany). Therefore, 1 mM
BrdU labeling solution was added to the cells during treatment for
48 hours. Detection was done according to the manufactures’
instructions. Absorbance was measured at 370 nm wavelength
with a spectrophotometer (MultiscanH Spectrum; Thermo). The
tests were done as triplicates of hTM from 5 different donors in 3
independent experiments. Values represent mean averages 6 SD
(n=45).
RNA isolation and real-time PCR
Total RNA was isolated with a RNA isolation kit (RNeasy
Fibrous Tissue Mini Kit; Qiagen N.V., Hilden, Germany)
according to the manufactures’ instructions. Structural integrity
of the RNA samples was confirmed by electrophoresis in 1%
Tris-acetate-EDTA (TAE)-agarose gels [32]. Yield and purity
were determined photometrically. 200 ng of mRNA were
transcribed to cDNA by reverse transcription using a reverse
transcription-PCR kit (Access RT-PCR Introductory System;
Promega Corporation, Madison, USA). Real-time PCR quanti-
fication was performed in 40 cycles in a thermocycler (Light-
Cycler System; Roche Diagnostics, Penzberg, Germany). The
selected primers for FN, PAI-1, CTGF, Hsp27, Hsp90, IL-1a,
IL-6, IL-8, NFkB and glycerinaldehyd-3-phosphat-dehydroge-
nase (GAPDH) were purchased from Metabion (Metabion
International AG, Martinsried, Germany); primer sequences
are summarized in Table 1. Corresponding probes were selected
with the ProbeFinder v2.04 software (Roche). The standard
curve was obtained from probes of three different untreated
hTM cultures. As internal control GAPDH was processed
simultaneously in each assay and levels of FN-1, PAI-1, CTGF,
Hsp27, Hsp90, IL-1a, IL-6, IL-8 and NFkBm R N A sw e r e
determined as relative ratios (RR) by division by GAPDH.
Ratios in non-supplemented cells without H2O2 treatment were
set to one and expression levels of treated cells are given as fold
of that. All experiments were performed in triplicates with TM
cultures from three different donors. Values represent mean
averages 6 SD (n=9).
Protein isolation and western blot
Media of hTM were collected separately and concentrated six
fold by centrifugation (Vivaspin20; Sartorius Stedim GmbH,
Goettingen, Germany). Cells were directly lysed in RIPA buffer
(150 mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS, 50 mM
Tris [pH 8.0], 4 mM DTT, 0.5 mM NaVanadate, 2 mM NaF,
2 mM phenylmethylsulfonyl fluoride) containing protease inhib-
itors (complete protease inhibitor cocktail; Roche). Protein
contents of concentrated media and cell lysates were determined
by the bicinchoninic acid (BCA) protein assay (Pierce, Rockford,
USA). Samples were supplemented with one fourth SDS-loading
buffer (Roti-load-1; Roth, Karlsruhe, Germany) and aliquots
containing equal proteins were separated by SDS-polyacryl-
amide gel electrophoresis (PAGE). Proteins were transferred onto
a nitrocellulose membrane (Protran Ba-183; Whatman, Dassel,
Germany) by semi-dry or tank blotting. Further procedure was
done as previously described [33] and primary antibodies
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secondary alkaline phosphatase (AP) -conjugated antibodies
(Table 2) were incubated for 30 minutes at room temperature.
After substrate incubation (CDP-star; Roche) the signals were
visualized by exposure to light sensitive films (Hyperfilm ECL;
GE Healthcare, Munich, Germany), which were digitized and
densitometrically quantified with the Multi Gauge V3.1 software
(Fujifilm, Duesseldorf, Germany). All experiments were per-
formed in triplicates with hTM cultures from three different
donors. Values represent mean averages 6 SD (n=9).
Fibronectin ELISA
Medium contents for FN were analyzed by ELISA according to
the manufacturer’s instructions (QuantiMatrix Human Fibronec-
tin ELISA KIT; Millipore, Schwalbach, Germany). Aliquots of
50 ml of six-fold concentrated cell media were set in. Absorbance
at 450 nm was measured with a spectrophotometer (MultiscanH
Spectrum; Thermo). Measurements were done as triplicates of
media from hTM cultures of 3 different donors in 3 independent
experiments. Values represent mean averages 6 SD (n=9).
Interleukin ELISAs
Amounts of secreted Interleukins (IL) -6 and -8 were analyzed
by ELISA according to the manufacturer’s instructions (Quanti-
Glo Chemiluminescent ELISA; R&D Systems, Minneapolis,
USA). Aliquots of 100 ml and 50 ml of six-fold concentrated cell
media were used for IL-6 and IL-8 determination, respectively.
Light emission was measured with a luminometer (Fluoroskan
Ascent FL; Thermo). Measurements were done as triplicates of
hTM cell media from 3 different donors in 3 independent
experiments. Values represent mean averages 6 SD (n=9).
Nuclear Factor (NF) kB Assay
Nuclear content of NFkB was tested in nuclear extracts with a
NoShift
TM NFkB Transcription Factor Assay (Novagen/Merck,
Darmstadt, Germany) according to the manufacturer’s instruc-
tions. For nuclear extracts, cells were collected from plates with
Trypsine/EDTA (PAN
TM), washed three times in Hank’s buffered
salt solution (HBBS; PAN
TM) and lysed in three times packed cell
volumes of low-salt hypotonic cell lysis buffer (20 mM HEPES
pH 7.5, 10 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 0.1%
TritonX-100, 10% glycerol, protease inhibitor cocktail [Roche])
for 10 min on ice. Nuclei were pelleted by centrifugation for
10 sec at 4uC and cytosolic fractions (supernatants) were
discarded. Nuclei were washed once in low-salt hypotonic cell
lysis buffer, and extracted using high-salt hypotonic cell lysis buffer
(low-salt supplemented to 500 mM NaCl) for 10 min on ice.
Debris was sedimented by centrifugation for 30 min at 4uC and
nuclear extracts were transferred to fresh vials. After BCA protein
determination extracts were stored at 280uC until use. For assays,
equal masses of proteins were set in. Quantification was done by
measurement of the absorbance at 450 nm with a spectropho-
tometer (MultiscanH Spectrum; Thermo). Measurements were
done as triplicates of nuclear extracts of hTM cell cultures from 3
different donors in 3 independent experiments. Values represent
mean averages 6 SD (n=9).
Immunofluorescence (IF) labeling
hTM were grown for 48 hours on microscope chamber slides
(Lab-TekHII; Nunc, Rochester, USA). After depicted treat-
ments, slides were fixed in 4% paraformaldehyde (PFA), blocked
in PBS (1% BSA, 0.1% Triton X-100) and primary antibodies
(Table 2) were added in PBS (2% BSA, 0.2% Triton X-100)
overnight at 4uC. Fluorophor conjugated secondary antibodies
(Table 2) in PBS were added for 30 minutes at room
temperature. The F-actin cytoskeleton was labeled by fluores-
cein conjugated phalloidin (Molecular Probes
TM, Eugene, USA)
for 15 minutes at room temperature. Nuclei were counter-
stained by 49,69-diamidino-2-phenylindole (DAPI; Molecular
Probes
TM). Cells were mounted in fluorescent mounting
medium (Dako, Glostrup, Denmark) and analyzed by Laser
confocal microscopy (Carl Zeiss, Goettingen, Germany). All
experiments were performed in triplicates with hTM cultures
from three different donors (n=9).
Statistical analysis
Statistical analysis was done by a Student’s t-test with the
GraphPad Prism5 software (*p#0.05; **p#0.01; ***p#0.001).
Table 1. Primers used for realtime PCR.
Gene Sequence Probe
Hsp27 fwd.: 59-tgacggtcaagaccaagga-39 22
rev.: 59-tgtagccatgctcgtcctg-39
Hsp90 fwd.: 59-ggagaattctacaagagcctcact-39 48
rev.: 59-tgaccttctacagaaaagtgcttg-39
FN fwd.: 59-ctggccgaaaatacattgtaaa-39 32
rev.: 59-ccacagtcgggtcaggag-39
PAI-1 fwd.: 59-aaggcacctctgagaacttca-39 19
rev.: 59-cccaggactaggcaggtg-39
CTGF fwd.: 59-ctgcaggctagagaagcagag -39 85
rev.: 59-gatgcactttttgcccttct-39
IL-1a fwd.: 59-acaaaaggcgaagaagactga-39 20
rev.: 59-ggaactttggccatcttgac-39
IL-6 fwd.: 59-caggagcccagctatgaact-39 45
rev.: 59-gaaggcagcaggcaacac-39
IL-8 fwd.: 59-agacagcagagcacacaagc-39 72
rev.: 59-atggttccttccggtggt-39
NFkB fwd.: 59-cgggatggcttctatgagg-39 47
rev.: 59-ctccaggtcccgcttctt-39
GAPDH fwd.: 59-agccacatcgctcagacac-39 60
rev.: 59-gcccaatacgaccaaatcc-39
doi:10.1371/journal.pone.0031340.t001
Table 2. Antibodies used for Western blots (WB) and
Immunofluorescence (IF) labeling.
Antibody
Dilution/
Application Supplier
Rabbit monoclonal anti-human Hsp27 1:1000 (WB) Sigma-Aldrich
Mouse monoclonal anti-human Hsp90 1:1000 (WB) Sigma-Aldrich
Rabbit polyclonal anti-human FN 1:1000 (WB) St.Cruz
Rabbit polyclonal anti-human PAI-1 1:500 (WB) Abcam
Rabbit polyclonal anti-human CTGF 1:1000 (WB) Abcam
AP conjugated goat anti-mouse IgG 1:10000 (WB) Sigma-Aldrich
AP conjugated goat anti-rabbit IgG 1:10000 (WB) Sigma-Aldrich
doi:10.1371/journal.pone.0031340.t002
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Mitochondrial activity analysis
Mitochondrial activity of primary hTM cultured under
standard conditions (controls) increased to 130611% over
48 hours (Fig. 1A). Cells supplemented with v-3 showed a similar
activity at the same time point (122616%; p=0.2211), whereas
the mitochondrial activity of cells preincubated with v-6 was
significantly lower at 8768% (***p#0.001; Fig. 1A) compared to
the controls.
Figure 1. CCK-8 assay. Quantification of mitochondrial activity in hTM after 48 hours normalized to starting activity in controls. (A) Effects of v-6
(16 mM) and v-3 (50 mM) fatty acids compared to controls (Co). (B) Effects of H2O2 in controls, v-6 and v-3 fatty acids pre-treated hTM. (C)% -
reduction of mitochondrial activity after H2O2 exposition. Values represent mean averages (m.a.) 6 standard deviations (sd) of three independent
experiments performed in triplicates of 5 different donors (n=45); asterisks: p-values of statistical significances (**p#0.01; ***p#0.001).
doi:10.1371/journal.pone.0031340.g001
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of controls to 6067% (***p#0.001; Fig. 1B), corresponding to a
71613% reduction (Fig. 1C). The mitochondrial activity of v-6
preincubated, H2O2 stimulated hTM was 39616% (***p#0.001;
Fig. 1B), corresponding to a 48617% (Fig. 1C) reduction
compared to the v-6-only incubated hTM. hTM preincubated
with v-3 in contrast, showed no significant reduction due to H2O2
(114621%; Fig. 1B; reduction 5618% Fig. 1C). Compared to the
controls H2O2 mediated reductions were significantly reduced in
both, v-6 (**p#0.01) and v-3 (***p#0.001) preincubated hTM
(Fig. 1C).
Proliferation analysis
Controls had a mean BrdU incorporation rate of 168634%
after 48 hours normalized to t=0 hours. Cells preincubated with
v-3 showed a similar increase of incorporation rate as the controls
up to 184617% at 48 hours (p=0.2447). In contrast, v-6
preincubated cells’ incorporation rate remained rather constant
Figure 2. BrdU incorporation analysis. Quantification of proliferation rate in hTM after 48 hours normalized to starting activity in controls. (A)
Effects of v-6 (16 mM) and v-3 (50 mM) fatty acids compared to controls (Co). (B) Effects of H2O2 in controls, v-6 and v-3 fatty acids pre-treated hTM.
(C) %-reduction of BrdU-incorporation after H2O2 exposition. Values represent m.a. 6 sd of three independent experiments performed in triplicates of
5 different donors (n=45); asterisks: p-values of statistical significances (*p#0.05; **p#0.01; ***p#0.001).
doi:10.1371/journal.pone.0031340.g002
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significantly lower than in the controls and the v-3 supplemented
cells (***p#0.001; Fig. 2A).
H2O2 exposure reduced BrdU incorporation in controls by
97642% to 72615% (***p#0.001; Fig. 2B). In cells preincubated
with fatty acids the incorporation rates were not reduced by H2O2
and were in the same range as in the corresponding controls at
88611% (v-6) and 161626% (v-3; Fig. 2B). The corresponding
reductions were 8617% (v-6) and 23623% (v-3) respectively,
both being significantly lower than in the controls (***p#0.001;
Fig. 2C).
Expression of heat shock proteins (Hsp)
Hsp27 mRNA levels were significantly increased after preincu-
bation with v-6 by 1.560.3 fold (**p#0.01) normalized to the
controls (Fig. 3A). Preincubation with v-3, in contrast, significantly
decreased the mRNA level by 0.560.2 fold (***p#0.001; Fig. 3A).
On protein level, however, amounts of Hsp27 were equal in
controls and fatty acid preincubated cells (v-6: 0.862.2 fold;
p=0.1923; v-3: 0.960.1 fold; p=0.3503; Fig. 3B, C).
Hsp90 mRNA was increased by both fatty acids by 3368 fold
(v-6; ***p#0.001) and 1766 fold (v-3; ***p#0.001; Fig. 3A),
respectively. Hsp90 protein levels were also increased by both fatty
acids by 1.460.2 fold (v-6; *p#0.05) and 1.660.1 fold (v-3;
***p#0.001; Fig. 3B, C).
Expression of ECM components
v-6 fatty acid significantly increased the fibronectin (FN)
mRNA by 2.560.5 fold (***p#0.001) compared to controls, while
v-3 supplementation did not have a significant effect (1.560.8
fold; p=0.1158; Fig. 4A). Intracellular FN protein levels were not
changed upon fatty acid supplementation (v-6: 1.160.1 fold;
p=0.3073; v-3: 0.860.1 fold; p=0.0584; Fig. 4C, D), amounts of
secreted FN in the medium were also not affected (v-3: p=0.8279;
v-6: p=0.9382; Fig. 4G).
In the controls, H2O2 addition increased the FN mRNA by
3.760.7 fold (***p#0.001; Fig. 4B), and the intracellular FN
protein by 1.360.1 fold (***p#0.001; Fig. 4C, D). In v-6 pre-
treated cells, H2O2 led to a further increase of FN mRNA to
5.262.5 fold (*p#0.05), whereas the amount of intracellular FN
protein did not increase (1.560.1 fold) compared to the
corresponding controls (p=0.2168; Fig. 4C, D). Pre-treatment
with v-3 prevented the H2O2 stimulation of FN mRNA (1.661.1
fold; p=0.8420; Fig. 4B) and intracellular FN (0.660.1 fold;
***p#0.001; Fig. 4C, D). In ELISA analysis H2O2 increased FN in
the medium to 1.660.3 fold (*p#0.05). Both fatty acids appeared
to impede this stimulation, in case of v-3 even to a statistically
significant extent (*p#0.05; v-6: p=0.0573; Fig. 4G).
Plasminogen activator inhibitor (PAI-)1 mRNA expression was
significantly increased by 2.560.5 fold in v-6 supplemented cells
(*p#0.05), whereas v-3 reduced the expression level compared to
the controls (0.860.1 fold; ***p#0.001; Fig. 4A). On the protein
level, in contrast, PAI-1 was significantly increased to 1.560.1 fold
in v-3 supplemented cells (***p#0.001), while v-6 did not affect
PAI-1 protein levels (1.160.2 fold; p=0.3462; Fig. 4C, E).
Exposure to H2O2 stimulated PAI-1 mRNA expression in the
controls by 5.660.2 fold (***p#0.001) and cellular PAI-1 protein
levels were increased to 1.460.2 fold (**p#0.01; Fig. 4C, E). In
cells pre-treated with v-6 fatty acid the PAI-1 mRNA was not
further increased by H2O2 (3.161.1; p=0.3824). The same
applied for the PAI-1 protein levels, which remained constant after
H2O2 stimulation (1.360.1 fold; p=0.3276; Fig. 4C, E). In cells
preincubated with v-3 the PAI-1 mRNA expression even dropped
to 0.0560.02 fold after H2O2 addition (***p#0.001; Fig. 4B),
protein levels, however, were in the same range than in their
corresponding controls (1.260.1 fold; p=0.0598; Fig. 4C, E).
Connective tissue growth factor (CTGF) mRNA expression was
significantly upregulated in cells supplemented with fatty acids
compared to the controls (v-6:14.465.7 fold; ***p#0.001; v-3:
26.661.7 fold; ***p#0.001; Fig. 4A). The v-6 mediated activation
Figure 3. Hsp27 and Hsp90 expression analysis. (A) Quantification of realtime PCR expression analysis of Hsp27 and Hsp90 mRNAs in controls,
v-6 and v-3 fatty acids pre-treated hTM normalized to controls. (B) Western blot detection of cellular Hsp27, Hsp90 and actin protein in controls, v-6
and v-3 fatty acids pre-treated hTM. (C) Plot of densitometric quantifications of Hsp27 and Hsp90 protein expression in controls, v-6 and v-3 fatty
acids pre-treated hTM adjusted to actin expression and normalized to controls. Values represent m.a. 6 sd of three independent experiments
performed on cells of three different donors (n=9); asterisks: p-values of statistical significances (*p#0.05; **p#0.01; ***p#0.001).
doi:10.1371/journal.pone.0031340.g003
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fold increase (***p#0.001). Protein levels in v-3 treated cells were
not increased (1.160.1 fold; p=0.2721; Fig. 4C, F).
H2O2 addition induced expression of CTGF mRNA by
21.263.1 fold (***p#0.001) in the controls. In v-6 pre-treated
cells, H2O2 further increased mRNA expression to 23.768.6 fold
(*p#0.05), which was not observed in v-3 pre-treated cells
(26.7611.6; p=0.4423; Fig. 4B). On the protein level, H2O2
resulted in a weak, but significant upregulation of CTGF in the
controls (1.260.05 fold; **p#0.01). In v-6 pre-treated cells, H2O2
exposure led to a reduced protein level than in the corresponding
controls (1.160.05 fold; **p#0.01). In v-3 pre-treated cells, H2O2
exposure had no effect on CTGF protein level (1.060.05 fold;
p=0.1670 Fig. 4C, F).
Expression of Interleukins and NFkB
Expression of IL-1a mRNA was significantly stimulated by v-6
(7.561.0 fold; ***p#0.001), whereas v-3 had no effect (1.660.9
fold; p=0.3408; Fig. 5A). Exposition to H2O2 doubled IL-1a
mRNA expression (2.660.5 fold; **p#0.01; Fig. 5A). Neither v-3,
nor v-6 could significantly inhibited this stimulation (v-3:
p=0.0669; v-6: p=0.0596; Fig. 5A). Expression in H2O2/v-6
double treated cells appeared lower than in v-6 supplemented
hTM, differences, however, did not reach the level of statistical
significance (p=0.0513; Fig. 5A).
IL-6 mRNA expression was not altered by both fatty acids (v-3:
p=0.7306; v-6: p=0.2828; Fig. 5B). H2O2 stimulation increased
IL-6 mRNA to 3.461.4 fold (*p#0.05), which could not be
impeded by both fatty acids (v-3: p=0.1720; v-6: p=0.8920;
Fig. 5B). ELISA analysis of the medium revealed that v-6
stimulated IL-6 secretion (*p#0.05) which was not observed upon
v-3 supplementation (p=0.0791; Fig. 5D). H2O2 lead to a
1.660.3 fold induction of IL-6 protein (*p#0.05; Fig. 5D). Both
fatty acids appeared to reduce this stimulation, however, only the
effect of v-3 was significant (*p#0.05; v-6: p=0.1675; Fig. 5D).
IL-8 mRNA expression appeared to be slightly activated by
both fatty acids. However, this was statistically significant for v-3
only (**p#0.01; v-6: p=0.1017; Fig. 5C). Incubation with H2O2
increased IL-8 synthesis to 4.861.7 fold (*p#0.05), which could be
counteracted by v-3 supplementation (*p#0.05; Fig. 5C). Addition
of v-6 was inefficient here (p=0.2174). Analysis of IL-8 in the cells
medium indicated that fatty acids alone had no effect on IL-8
Figure 4. FN, PAI-1 and CTGF expression analysis. Quantitative realtime PCR expression analysis of FN, PAI-1 and CTGF mRNAs in controls, v-6
and v-3 fatty acids pre-treated hTM normalized to controls (A) before and (B) after H2O2 exposition. (C) Western blot detection of cellular FN, PAI-1,
CTGF, and actin in controls, v-6 and v-3 fatty acids pre-treated hTM. Plots of densitometric quantifications to deduce fold expressions of intracellular
(D) FN, (E) PAI-1 and (F) CTGF, before and after H2O2 exposition. (G) ELISA quantification of FN medium contents normalized to controls. Values
represent m.a. folds 6 sd of three independent experiments performed on cells of three different donors (n=9); asterisks: p-values of statistical
significances (*p#0.05; **p#0.01; ***p#0.001).
doi:10.1371/journal.pone.0031340.g004
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H2O2 led to a 2.060.2 fold increase of IL-8, which was statistically
significant (**p#0.01; Fig. 5E). With respect to H2O2 counterac-
tion, both fatty acids were ineffective (v-3: p=0.5258; v-6:
p=0.9256; Fig. 5E).
Realtime PCR analysis of NFkB expression did not reveal any
significant influences of both fatty acids on this transcription factor
(Fig. 6A). Data suggested that H2O2 slightly stimulated NFkB, but
statistical significance was not reached (p=0.1087; Fig. 6A).
Notably, such an indication of increase was not detected in fatty
acid supplemented hTM (Fig. 6A). On the protein level, a similar
regulation was observed. Fatty acids alone did not affect the
nuclear NFkB level, whereas H2O2, though insignificantly,
stimulated nuclear contents (Fig. 6B). Again, such a slight increase
was not observed in v-3 or v-6 supplemented hTM (Fig. 6B).
Changes of the F-actin cytoskeleton
Phalloidin labeling of F-actin revealed no explicit differences
between controls and fatty acid supplemented cells with respect to
formation of cross-linked actin networks (CLANs; Fig. 7A). It
appeared that v-6 treated cells tended to form increased numbers
of stress fibers than the controls as well as v-3 treated cells
(Fig. 7A). H2O2 exposure promoted accumulation of stress fibers
and CLAN formation (Fig. 7B) in the controls. In v-6
preincubated cells, CLAN formation and stress fibre accumulation
appeared even more pronounced (Fig. 7B) than in the stimulated
controls and in v-3 pre-treated cells. v-3 pre-treated cells showed
a similar frequency of CLANs and stress fibres as the unstimulated
controls (Fig. 7B).
Discussion
The current picture of glaucoma pathogenesis suggests that
combinatory events act synergistically on the basis of an individual
predisposition leading to the onset of the disease [34]. One factor
in the focus of investigative glaucoma research is oxidative stress
[35], as one of the main problems in glaucoma is an imbalance of
ROS formation and decomposition [1] resulting in ROS
accumulation [15,19,20] as well as general reduction of anti-
oxidant capacities. TM cells were shown to be especially sensitive
Figure 5. Interleukin 1a, -6 and -8 expression analysis. Quantitative realtime PCR expression analysis of interleukins (A)- 1 a,( B) -6 and (C)- 8
mRNAs in controls, hTM pre-treated with v-6 and v-3 before and after H2O2 exposition. ELISA quantification of (D) IL-6 and (E) IL-8 medium contents.
Values are normalized to untreated controls and represent m.a. folds 6 sd of three independent experiments performed on cells of three different
donors (n=9); asterisks: p-values of statistical significances (*p#0.05; **p#0.01; ***p#0.001).
doi:10.1371/journal.pone.0031340.g005
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synthesis [6], and basic cellular processes, like cell cycle control,
proliferation, apoptosis and cellular metabolism [36,37]. In this
respect, prophylactic intake of dietary supplements with alleged
antioxidant capacities is recommended for protection from
deleterious effects of oxidative stress and prevention of glaucoma
thereby.
The aim of this study was to test v-3 and v-6 fatty acids for their
abilities to antagonize H2O2 induced glaucomatous effects on
cellular activity, proliferation, stress response and ECM synthesis
using an in-vitro model based on primary human TM cells.
We found that v-6 inhibited the normal increase of metabolic
activity and proliferation during cultivation that was observed in
controls and v-3 supplemented cells. This suggests an anti-
proliferative, cytostatic capacity of v-6, which would agree to
reports about rather deleterious effects of excessive amounts of v-
6, including promotion of cardiovascular disease, inflammation,
autoimmune diseases or cancer [26,27,28], [38,39]. Though,
extended studies evaluating cell cycle and cell death are necessary
to make concrete assertions. In respect of their capacities to
prevent TM cells from H2O2 mediated reductions of metabolism
and proliferation, we also found differences for v-6 and v-3 fatty
acids. BrdU incorporation was efficiently stabilized by both, but
only v-3 rendered hTM unsusceptible against H2O2 mediated
reduction of mitochondrial activity.
Taken together, our data indicate inhibitory side effects of v-6
on metabolism and proliferation and a limited effectiveness in
prevention from oxidative stress. In conclusion, v-3 appeared to
be more beneficial for cellular protection.
Another cellular response to elevated oxidative stress levels is an
augmented synthesis of Hsps, which constitute active components
of cellular protection and rescue mechanisms [6,40,41,42]. Here
we analyzed two representatives of this protein family, Hsp27 and
Hsp90, which were found to be strongly expressed in glaucoma-
tous tissues, particularly in the TM. Hsp27 is considered an early
marker of cellular stress responses, and is alleged to be especially
protective against oxidative damage. Moreover, it was shown that
Hsp27 conveys an anti-apoptotic effect by modulation of the
nuclear factor (NF) kB-pathway. Hsp90 is also activated by
oxidative stress and acts as an essential chaperone maintaining
protein stability [42], including transcription factors that regulate
anti-apoptotic signaling-pathways.
Our data suggest that Hsp27 is not a direct target of v-6 and v-
3 fatty acids, as the observed regulations of the mRNA, although
statistically significant, did not manifest on the protein level.
Hsp90 in contrast, was strongly activated on the RNA level, and
also significantly increased on protein level by both supplements.
Based on the known functions of Hsp90, this could be interpreted
as a kind of cellular alert condition, with a constantly activated
mild stress response rendering the cells prepared for potential
exogenous threats. In the context of glaucoma prevention, this
would be favorable and argue for beneficial effects of v-6 and v-3
fatty acids in respect of stress control. Partial support is also added
by our data on NFkB and Interleukin synthesis. One feature of
oxidative stress is the onset of inflammatory processes that
promote disease progression in many neurodegenerative condi-
tions. Key players in this processes are NFkB, regulating
expression/secretion of pro-inflammatory cytokines [43]. Here
we found that fatty acids appeared to abolish the H2O2 mediated
stimulation of nuclear NFkB, which therefore could be interpreted
as an anti-inflammatory effect. Also the stimulation of IL-6, a key
pro-inflammatory interleukin and circumscribed oxidative stress
marker [44], was repressed by v-3 and v-6, for the former even to
a significant extent. However, our data on IL-1a and IL-8 did not
indicate any effect of fatty acids. Moreover, the observed changes
in protein levels were rather subtle, so we cautiously propose a
beneficial effect, denoting that this hypothesis requests extended
experimental approaches in future studies.
Another typical hallmark of the glaucomatous TM is the
accumulation of extracellular material in consequence of an
Figure 6. Analysis of nuclear NFkB. (A) Quantitative realtime PCR expression analysis of NFkB mRNA in controls, hTM pre-treated with v-6 and v-
3 before and after H2O2 exposition. (B) Quantification of nuclear NFkB protein contents. Values are normalized to untreated controls and represent
m.a. folds 6 sd of three independent experiments performed on cells of three different donors (n=9).
doi:10.1371/journal.pone.0031340.g006
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degradation. It has been already shown that oxidative stress
induces synthesis of various ECM components [5,35] and
accordingly we detected an increase of FN, PAI-1 and CTGF
mRNA and protein upon H2O2 exposition. The most obvious
effects were observed for FN, which was strongly increased in the
medium of v-6 supplemented and even more increased when the
cells were additionally exposed to H2O2, indicating a potential
synergistic effect. CTGF synthesis was also stimulated by v-6,
although significantly less than FN. Notably, there were no
indications for a synergistic effect of v-6 and H2O2. v-3 fatty acid
did not have significant effects on FN and CTGF expression, but
antagonized the H2O2 mediated stimulation of both proteins. An
obvious effect, however, was detected on PAI-1 expression, which
was activated by v-3. Notably, exposition to H2O2 resulted in
lower PAI-1 expression than in the corresponding controls,
indicating a similar antagonizing effect as observed with CTGF
and FN. Summarized, it appeared that v-6 fatty acid alone
seemed to stimulate ECM synthesis and v-3 fatty acid seemed to
prevent ECM degradation via activation of PAI-1, both effects
that would favor ECM accumulation in the context of glaucoma
disease. Paradoxically, both fatty acids seem to have the ability to
antagonize the H2O2 mediated stimulations, thus indicating an
overall protective effect.
Morphologically, we observed an increased formation of
CLANs and intracellular stress fibers after H2O2 stimulation, a
frequent finding in glaucomatous TM cells [5,45,46,47,48,49,50].
Here, only preemptive application of v-3 had a preventive effect
on formation of these stress indicators.
To sum up, v-6 was efficient in preventing H2O2 mediated anti-
proliferative effects, but displayed a repressive effect on mitochon-
drial activity and proliferation. For v-3, we observed no negative
side effects but an effective potential to prevent H2O2 mediated
anti-proliferative/-metabolic effects. Both agents induced Hsp90,
which can be interpreted in terms of a cellular precaution to
forthcoming insults. Considering matrix synthesis, both fatty acids
were pro-fibrotic, but still could antagonize H2O2 stimulation.
Lastly, v-3 was effective in prevention from CLAN and stress fiber
formation.
Based on this, we conclude that v-3 to seems be the more
beneficial fatty acid, whereas v-6 appears more critical and not
unreservedly recommendable. This agrees with reported cytotoxic
side effects of high-dose v-6 [26,27,28,38,39,51]. Future studies
including other vulnerable ocular cell types will have to prove if
preemptive dietary with v-3 helps to prevent deleterious effects of
oxidative stress in glaucoma and other age-associated degenerative
diseases, and will have to further challenge the eligibility of v-6 as
a protective nutritional supplement.
Figure 7. F-actin labelling. Phalloidin labeling of the F-actin cytoskeleton in controls, v-6 and v-3 supplemented hTM (A) before and (B) after
H2O2 exposition; scale bar: 100 mm.
doi:10.1371/journal.pone.0031340.g007
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